LUCINDA ROSS: Open Payments
NPI 1831340389 · SALT LAKE CITY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$501 in 21 payments from 13 companies in 2025. Trend: 2023 $919 · 2024 $1,153 · 2025 $501
Food & beverage: $501
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 3 | $76 |
| Novartis Pharmaceuticals Corporation | 3 | $76 |
| Exeltis, USA Inc. | 1 | $67 |
| BETA BIONICS, INC. | 4 | $62 |
| Sequel Med Tech, LLC | 1 | $38 |
| Abbott Laboratories | 2 | $37 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $32 |
| Alexion Pharmaceuticals, Inc. | 1 | $24 |
| Chiesi USA, Inc. | 1 | $24 |
| Tandem Diabetes Care, Inc. | 1 | $21 |
Products named: EVENITY, LEQVIO, TWIRLA, iLet Bionic Pancreas, TWIIST, FREESTYLE LIBRE 3, ISTURISA, STRENSIQ.
Industry payments across UT — which companies pay providers there.
